Elsevier

Life Sciences

Volume 59, Issue 3, 14 June 1996, Pages 169-195
Life Sciences

Minireview
Pharmacology of barbiturate tolerance/dependence: GABAa receptors and molecular aspects

https://doi.org/10.1016/0024-3205(96)00199-3Get rights and content

Abstract

Barbiturates are central nervous system depressants that are used as sedatives, hypnotics, anesthetics and anticonvulsants. However, prolonged use of the drugs produces physical dependence, and the drugs have a high abuse liability. The gamma-aminobutyric acidA (GABAA) receptor is one of barbiturates' main sites of action, and therefore it is thought to play a pivotal role in the development of tolerance to and dependence on barbiturates. Recent advances in the study of the GABAA receptor/chloride channel complex allow us to examine possible mechanisms that underlie barbiturate tolerance/dependence in a new light. In this minireview, we mainly focus on molecular and cellular aspects of the action of barbiturates and the possible mechanisms that contribute to development of tolerance to and dependence on barbiturates.

References (176)

  • J.A. Richter et al.

    Prog. Neurobiol.

    (1982)
  • P.V. Taberner

    Comp. Biochem. Physiol.

    (1989)
  • S. Yu et al.

    Alcohol

    (1990)
  • N. Bowery

    Trends Pharmacol. Sci.

    (1989)
  • D.D. Mott et al.

    Int. Rev. Neurobiol.

    (1994)
  • S.O. Casalotti et al.

    J. Biol. Chem.

    (1986)
  • K. Fuchs et al.

    Neurosci. Lett.

    (1988)
  • G. Smith et al.

    Trends Pharmacol. Sci.

    (1995)
  • A. Doble et al.

    Trends Pharmacol. Sci.

    (1992)
  • H. Lüddens et al.

    Neuropharmacology

    (1995)
  • R.F. Squires et al.

    Pharmacol. Biochem. Behav.

    (1979)
  • C.P. Miralles et al.

    Mol. Brain Res.

    (1994)
  • R.D. Schwartz et al.

    FEBS Lett.

    (1984)
  • M. Robello et al.

    Neuroscience

    (1993)
  • S.J. Moss et al.

    J. Biol. Chem.

    (1992)
  • B.J. Mcdonald et al.

    J. Biol. Chem.

    (1994)
  • D.D. Mckinley et al.

    Mol. Brain Res.

    (1995)
  • C.F. Valenzuela et al.

    Mol. Brain Res.

    (1995)
  • R.A. Lanius et al.

    Mol. Brain Res.

    (1993)
  • N.M. Porter et al.

    Neuron

    (1990)
  • O. Moran et al.

    Mol. Brain Res.

    (1989)
  • E. Sigel et al.

    FEBS Lett.

    (1991)
  • B.J. Krishek et al.

    Neuron

    (1994)
  • P.R. Andrews et al.

    Eur. J. Pharmacol.

    (1979)
  • E. Sigel et al.

    Neuron

    (1990)
  • M.K. Ticku et al.

    Life Sci.

    (1983)
  • G. Maksay et al.

    Life Sci.

    (1985)
  • K.A. Wafford et al.

    Neuron

    (1991)
  • E.H.F. Wong et al.

    Brain Res.

    (1984)
  • W.W. Morgan

    Adv. Alcohol Subst. Abuse

    (1990)
  • I.K. Ho et al.

    Ann. Rev. Pharmacol. Toxicol.

    (1981)
  • P.A. Saunders et al.

    Prog. Drug Res.

    (1990)
  • R.W. Olsen et al.

    Ann. Ny Acad. Sci.

    (1991)
  • R.L. Macdonald et al.

    Ann. Rev. Neurosci.

    (1994)
  • R.F Tyndale et al.
  • W. Sieghart

    Pharmacol. Rev.

    (1995)
  • P. Whiting et al.
  • P. Kofuji et al.

    J. Neurochem.

    (1991)
  • J. Amin et al.

    Nature

    (1993)
  • W. Sieghart et al.

    J. Neurochem.

    (1987)
  • D.M. Turner et al.

    J. Pharmacol. Exp. Ther.

    (1991)
  • R.W. Olsen et al.

    J. Chem. Neuroanat.

    (1990)
  • D.J. Laurie et al.

    J. Neurosci.

    (1992)
  • E. Persohn et al.

    J. Comp. Neurol.

    (1992)
  • W. Wisden et al.

    J. Neurosci.

    (1992)
  • B. Sakmann et al.

    J. Neural Transm. Supple.

    (1983)
  • R.L. Macdonald et al.

    J. Physiol.

    (1989)
  • D.S. Weiss et al.

    J. Neurosci.

    (1989)
  • R.E. Twyman et al.

    J. Physiol.

    (1990)
  • R.L. Macdonald et al.

    Ion Channels

    (1992)
  • Cited by (60)

    • Sedative-hypnotic effect and in silico study of dinaphthodiospyrols isolated from Diospyros lotus Linn

      2021, Biomedicine and Pharmacotherapy
      Citation Excerpt :

      The decline in calcium level will not be able to accelerate the neurotransmitter containing vesicle and so further interaction of neurotransmitters and receptors will be minimized and body overlay is considered as inhibited i.e. sedative or hypnotic. The findings revealed that benzodiazepines increase the activity of the GABAA receptor by binding to its gamma subunit, resulting in structural changes to the GABAA-receptor [24–26]. Furthermore, benzodiazepines do not replace GABA, which binds to the -subunit, but they do increase the frequency of channel opening events, resulting in an increase in chloride ion (Cl-) conductance and inhibiting action potentiality.

    • Drug instrumentalization

      2020, Behavioural Brain Research
      Citation Excerpt :

      Alcohol can attenuate stress levels by inhibiting excitatory glutamatergic transmission and enhancing inhibitory GABAergic activity in the brain [303]. Furthermore, barbiturates and benzodiazepines most likely exert their stress-reducing effects by the modulation of GABAA receptors [119], although at different binding sites from alcohol. They also allosterically increase the responses to GABA [5].

    • Non-pharmacological factors that determine drug use and addiction

      2020, Neuroscience and Biobehavioral Reviews
      Citation Excerpt :

      Two of the major pharmacological effects of alcohol are the inhibition of excitatory glutamatergic transmission and enhancement of inhibitory GABAergic activity (Spanagel, 2009). Barbiturates and benzodiazepines also modulate the GABAA-receptor (Ito et al., 1996), though at other binding sites than alcohol, and allosterically enhance responses to the inhibitory transmitter GABA (Allison and Pratt, 2003). Enhanced GABAA-receptor signaling may reduce innate anxiety and conditioned anxiety.

    • Rats treated with Hypericum perforatum during pregnancy generate offspring with behavioral changes in adulthood

      2017, Revista Brasileira de Farmacognosia
      Citation Excerpt :

      Such facts added to the hypothesis that Hp can cross the placental barrier could justify the results found in this work in which the use of Hp extract by pregnant mothers indicated reduction of the depressive- and anxious-like state of the descendants. Therefore, it is suggested that treatment with Hp extract during gestation has generated tolerance in the developing SNC of the fetuses (down-regulation) (Ito et al., 1996; Stahl, 1998; Liang et al., 2007). As neurodevelopment continues postnatally with the increase in the number of neurotransmitter receptors, such as 5-HT (Gaspar et al., 2003), NOR (Murrin et al., 2007) and GABA (Xia and Haddad, 1992), it is believed that a rebound increase in the number of these receptors (upregulation) has occurred during this period, which was able to reprogram regions of the brain related to anxiety and depressive behavior (such as the hippocampus) to a new state of normality.

    View all citing articles on Scopus
    View full text